Results 171 to 179 of about 82,921 (179)

Peg-Asparaginase Associated Toxicities in Children with Acute Lymphoblastic Leukemia

OncoDaily Medical Journal
Sameh Awwad, Fahad Almanjomi, Murtada Alsultan, Mohammad Alomtari, Rawan Abulnasr   +4 more
openaire   +1 more source

Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study

Leukemia, 2008
Joachim Boos, Rob Pieters, Pieters R
exaly  

Regulation of Catalytic Activity of Recombinant L-Asparaginase from Rhodospirillum rubrum by Conjugation with a PEG-Chitosan Copolymer

Moscow University Chemistry Bulletin, 2018
Elena Kudryashova, M V Pokrovskaya, N N Sokolov   +2 more
exaly  

Asparagine Concentration in Plasma After 2 500 IU/m² PEG-Asparaginase i.v. in Children With Acute Lymphoblastic Leukemia

Klinische Padiatrie, 2005
Alfried Kohlschütter, Joachim Boos, Johannes E Wolff   +2 more
exaly  

PEG‐asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol

Pediatric Blood and Cancer, 2015
Kjeld Schmiegelow, Birgitte Klug Albertsen, Jonas Abrahamsson   +2 more
exaly  

The correlation of asparaginase enzyme activity levels after PEG‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia

British Journal of Haematology
Shaohua Le, Cai Chen
exaly  

Up-front therapy with PEG-asparaginase in the treatment of ALL in children

2009
Henriksen, LT, Albertsen, Birgitte Klug; id_orcid 0000-0002-3902-3694, Schrøder, Henrik, Rosthøj, Steen, Carlsen, N, Thomassen, H, Sabel, M   +6 more
openaire   +1 more source

PHARMACEUTICAL COMPOSITIONS COMPRISING PEG-ASPARAGINASE FOR THE TREATMENT OF HIV INFECTIONS

1999
AVRAMIS VASSILIOS I, COHEN LEWIS
openaire   +2 more sources

PHARMACEUTICAL COMPOSITION COMPRISING PEG-ASPARAGINASE FOR THE TREATMENT OF HIV INFECTION

2002
AVRAMIS VASSILIOS L, COHEN LEWIS
openaire   +1 more source